{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:46:53Z","timestamp":1784260013292,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s40272-017-0213-9","type":"journal-article","created":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T04:51:01Z","timestamp":1485924661000},"page":"113-120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Inflammatory Bowel Disease-Unclassified in Children: Diagnosis and Pharmacological Management"],"prefix":"10.1007","volume":"19","author":[{"given":"Giulia","family":"D\u2019Arcangelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7404-4004","authenticated-orcid":false,"given":"Marina","family":"Aloi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,1]]},"reference":[{"issue":"suppl A","key":"213_CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1155\/2005\/269076","volume":"19","author":"MS Silverberg","year":"2005","unstructured":"Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, et al. Towards an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(suppl A):5\u201336.","journal-title":"Can J Gastroenterol"},{"key":"213_CR2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ibd.23013","volume":"12","author":"A Levine","year":"2013","unstructured":"Levine A, de Bie CI, Turner D, Cucchiara S, Sladek M, Murphy MS, et al. Atypical disease phenotypes in pediatric ulcerative colitis: 5-year analyses of the EUROKIDS Registry. Inflamm Bowel Dis. 2013;12:370\u20137.","journal-title":"Inflamm Bowel Dis"},{"key":"213_CR3","doi-asserted-by":"crossref","first-page":"e1278","DOI":"10.1542\/peds.2008-2306","volume":"122","author":"C Romano","year":"2008","unstructured":"Romano C, Famiani A, Gallizzi R, Comito R, Ferrau V, Rossi P. Indeterminate colitis: a distinctive clinical pattern of inflammatory bowel disease in children. Pediatrics. 2008;122:e1278\u201381.","journal-title":"Pediatrics"},{"key":"213_CR4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/MPG.0000000000000239","volume":"58","author":"A Levine","year":"2014","unstructured":"Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L, et al. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58:795\u2013806.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"213_CR5","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.crohns.2014.04.005","volume":"8","author":"FM Ruemmele","year":"2014","unstructured":"Ruemmele FM, Veres G, Kolho KL, Griffiths A, Levine A, Escher JC, et al. Consensus guidelines of ECCO\/ESPGHAN on the medical management of pediatric Crohn\u2019s disease. J Crohns Colitis. 2014;8:1179\u2013207.","journal-title":"J Crohns Colitis"},{"key":"213_CR6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/MPG.0b013e3182662233","volume":"55","author":"D Turner","year":"2012","unstructured":"Turner D, Levine A, Escher JC, Griffiths AM, Russell RK, Dignass A, et al. Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr. 2012;55:340\u201361.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"213_CR7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.crohns.2009.07.001","volume":"3","author":"F Prenzel","year":"2009","unstructured":"Prenzel F. Uhlig HH Frequency of indeterminate colitis in children and adults with IBD\u2014a metaanalysis. J Crohns Colitis. 2009;3:277\u201381.","journal-title":"J Crohns Colitis"},{"key":"213_CR8","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1097\/MIB.0000000000000483","volume":"21","author":"DA Winter","year":"2015","unstructured":"Winter DA, Karolewska-Bochenek K, Lazowska-Przeorek I, Lionetti P, Mearin ML, Chong SK, et al. Pediatric IBD-unclassified is less common than previously reported; results of an 8-year audit of the EUROKIDS registry. Inflamm Bowel Dis. 2015;21:2145\u201353.","journal-title":"Inflamm Bowel Dis"},{"key":"213_CR9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.MPG.0000162479.74277.86","volume":"41","author":"S Auvin","year":"2005","unstructured":"Auvin S, Molini\u00e9 F, Gower-Rousseau C, Brazier F, Merle V, Grandbastien B, et al. Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988\u20131999). J Pediatr Gastroenterol Nutr. 2005;41:49\u201355.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"213_CR10","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/ibd.20470","volume":"14","author":"M Castro","year":"2008","unstructured":"Castro M, Papadatou B, Baldassare M, Balli F, Barabino A, Barbera C, et al. Inflammatory bowel disease in children and adolescents in Italy: data from the pediatric national IBD register (1996\u20132003). Inflamm Bowel Dis. 2008;14:1246\u201352.","journal-title":"Inflamm Bowel Dis"},{"key":"213_CR11","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/MPG.0b013e31829f7d8c","volume":"57","author":"KE M\u00fcller","year":"2013","unstructured":"M\u00fcller KE, Lakatos PL, Arat\u00f3 A, Kov\u00e1cs JB, V\u00e1rkonyi \u00c1, Sz\u0171cs D, et al. Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2013;57:576\u201382.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"213_CR12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/01.MIB.0000215093.62245.b9","volume":"12","author":"RS Carvalho","year":"2006","unstructured":"Carvalho RS, Abadom V, Dilworth HP, Thompson R, Oliva-Hemker M, Cuffari C. Indeterminate colitis: a significant subgroup of pediatric IBD. Inflamm Bowel Dis. 2006;12:258\u201362.","journal-title":"Inflamm Bowel Dis"},{"key":"213_CR13","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/01.MIB.0000442921.77945.09","volume":"20","author":"M Aloi","year":"2014","unstructured":"Aloi M, Lionetti P, Barabino A, Guariso G, Costa S, Fontana M, et al. Phenotype and disease course of early-onset pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:597\u2013605.","journal-title":"Inflamm Bowel Dis"},{"key":"213_CR14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jpeds.2015.04.045","volume":"167","author":"M Oliva-Hemker","year":"2015","unstructured":"Oliva-Hemker M, Hutfless S, Al Kazzi ES, Lerer T, Mack D, LeLeiko N, et al. Clinical presentation and five-year therapeutic management of very early-onset inflammatory bowel disease in a large north American cohort. J Pediatr. 2015;167:527\u201332.","journal-title":"J Pediatr"},{"key":"213_CR15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/ecco-jcc\/jjw118","volume":"11","author":"J Kammermeier","year":"2017","unstructured":"Kammermeier J, Dziubak R, Pescarin M, Drury S, Godwin H, Reeve K, et al. Phenotypic and genotypic characterisation of inflammatory bowel disease presenting before the age of 2 years. J Crohns Colitis. 2017;11:60-69.","journal-title":"J Crohns Colitis"},{"key":"213_CR16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jpeds.2004.08.043","volume":"146","author":"MB Heyman","year":"2005","unstructured":"Heyman MB, Kirschner BS, Gold BD, Ferry G, Baldassano R, Cohen SA, et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr. 2005;146:35\u201340.","journal-title":"J Pediatr"},{"key":"213_CR17","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00054725-200608000-00002","volume":"12","author":"P Turunen","year":"2006","unstructured":"Turunen P, Kolho KL, Auvinen A, Iltanen S, Huhtala H, Ashorn M. Incidence of inflammatory bowel disease in Finnish children, 1987\u20132003. Inflamm Bowel Dis. 2006;12:677\u201383.","journal-title":"Inflamm Bowel Dis"},{"issue":"21","key":"213_CR18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3748\/wjg.v21.i1.21","volume":"7","author":"GE Tontini","year":"2015","unstructured":"Tontini GE, Vecchi M, Pastorelli L, Neurath MF, Neumann H. Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives. World J Gastroenterol. 2015;7(21):21\u201346.","journal-title":"World J Gastroenterol"},{"key":"213_CR19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/jpsu.2003.50015","volume":"38","author":"F Alexander","year":"2003","unstructured":"Alexander F, Sarigol S, DiFiore J, Stallion A, Cotman K, Clark H, et al. Fate of the pouch in 151 pediatric patients after ileal pouch anal anastomosis. J Pediatr Surg. 2003;38:78\u201382.","journal-title":"J Pediatr Surg"},{"key":"213_CR20","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1111\/j.1572-0241.2002.05915.x","volume":"97","author":"P Mamula","year":"2002","unstructured":"Mamula P, Telega GW, Markowitz JE, Brown KA, Russo PA, Piccoli DA, et al. Inflammatory bowel disease in children 5\u00a0years of age and younger. Am J Gastroenterol. 2002;97:2005\u201310.","journal-title":"Am J Gastroenterol"},{"key":"213_CR21","first-page":"2939","volume":"96","author":"V Annese","year":"2001","unstructured":"Annese V, Andreoli A, Astegiano M, Campieri M, Caprilli R, Cucchiara S, et al. Clinical features in familial cases of Crohn\u2019s disease and ulcerative colitis in Italy: a GISC study. Italian Study Group for the Disease of Colon and Rectum. Am J Gastroenterol. 2001;96:2939\u201345.","journal-title":"Am J Gastroenterol"},{"key":"213_CR22","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1097\/MIB.0000000000000767","volume":"22","author":"M Aloi","year":"2016","unstructured":"Aloi M, Birimberg-Schwartz L, Buderus S, Hojsak I, Fell JM, Bronsky J, et al. Treatment Options and Outcomes of Pediatric IBDU Compared with Other IBD Subtypes: A Retrospective Multicenter Study from the IBD Porto Group of ESPGHAN. Inflamm Bowel Dis. 2016;22:1378\u201383.","journal-title":"Inflamm Bowel Dis."},{"key":"213_CR23","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/ibd.21551","volume":"17","author":"J Rimola","year":"2011","unstructured":"Rimola J, Ord\u00e1s I, Rodriguez S, Garc\u00eda-Bosch O, Aceituno M, Llach J, et al. Magnetic resonance imaging for evaluation of Crohn\u2019s disease: validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis. 2011;17:1759\u201368.","journal-title":"Inflamm Bowel Dis"},{"key":"213_CR24","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/gutjnl-2014-307008","volume":"64","author":"FM Ruemmele","year":"2015","unstructured":"Ruemmele FM, Hyams JS, Otley A, Griffiths A, Kolho KL, Dias JA, et al. Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee. Gut. 2015;64:438\u201346.","journal-title":"Gut"},{"key":"213_CR25","doi-asserted-by":"crossref","unstructured":"Subramanian S, Ekbom A, Rhodes JM. Recent advances in clinical practice: a systematic review of isolated colonic Crohn\u2019s disease: the third IBD? Gut.\u00a02017;66:362-381.","DOI":"10.1136\/gutjnl-2016-312673"},{"key":"213_CR26","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0016-5085(98)70252-5","volume":"115","author":"FM Ruemmele","year":"1998","unstructured":"Ruemmele FM, Targan SR, Levy G, Dubinsky M, Braun J, Seidman EG. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology. 1998;115:822\u20139.","journal-title":"Gastroenterology"},{"key":"213_CR27","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1572-0241.2007.01648.x","volume":"103","author":"P Vandewalle-El Khoury","year":"2008","unstructured":"Vandewalle-El Khoury P, Colombel JF, Joossens S, Standaert-Vitse A, Collot M, Halfvarson J, et al. Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn\u2019s disease patients and contributes to differential diagnosis, stratification, and prediction. Am J Gastroenterol. 2008;103:949\u201357.","journal-title":"Am J Gastroenterol"},{"key":"213_CR28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ajg.2010.505","volume":"106","author":"PL Lakatos","year":"2011","unstructured":"Lakatos PL, Papp M, Rieder F. Serologic antiglycan antibodies in inflammatory bowel disease. Am J Gastroenterol. 2011;106:406\u201312.","journal-title":"Am J Gastroenterol"},{"key":"213_CR29","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1111\/j.1572-0241.2006.00840.x","volume":"101","author":"GE Reese","year":"2006","unstructured":"Reese GE, Constantinides VA, Simillis C, Darzi AW, Orchard TR, Fazio VW, et al. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Am J Gastroenterol. 2006;101:2410\u201322.","journal-title":"Am J Gastroenterol"},{"key":"213_CR30","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1097\/MIB.0000000000000784","volume":"22","author":"L Birimberg-Schwartz","year":"2016","unstructured":"Birimberg-Schwartz L, Wilson DC, Kolho KL, Karolewska-Bochenek K, Afzal NA, Spray C, et al. pANCA and ASCA in Children with IBD-Unclassified, Crohn\u2019s Colitis, and Ulcerative Colitis\u2014A Longitudinal Report from the IBD Porto Group of ESPGHAN. Inflamm Bowel Dis. 2016;22:1908\u201314.","journal-title":"Inflamm Bowel Dis"},{"key":"213_CR31","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/gast.2002.32980","volume":"122","author":"S Joossens","year":"2002","unstructured":"Joossens S, Reinisch W, Vermeire S, Sendid B, Poulain D, Peeters M, et al. The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology. 2002;122:1242\u20137.","journal-title":"Gastroenterology"},{"key":"213_CR32","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/ibd.21903","volume":"18","author":"L Prideaux","year":"2012","unstructured":"Prideaux L, De Cruz P, Ng SC, Kamm MA. Serological antibodies in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis. 2012;18:1340\u201355.","journal-title":"Inflamm Bowel Dis"},{"key":"213_CR33","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1053\/j.gastro.2008.02.083","volume":"134","author":"P Stein von","year":"2008","unstructured":"von Stein P, Lofberg R, Kuznetsov NV, Gielen AW, Persson JO, Sundberg R, et al. Multigene analysis can discriminate between ulcerative colitis, Crohn\u2019s disease, and irritable bowel syndrome. Gastroenterology. 2008;134:1869\u201381.","journal-title":"Gastroenterology"},{"key":"213_CR34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/00365521.2011.647065","volume":"47","author":"I Janczewska","year":"2012","unstructured":"Janczewska I, Kapraali M, Saboonchi F, Nekzada Q, Wessulv \u00c5, Khoshkar J, et al. Clinical application of the multigene analysis test in discriminating between ulcerative colitis and Crohn\u2019s disease: a retrospective study. Scand J Gastroenterol. 2012;47:162\u20139.","journal-title":"Scand J Gastroenterol"},{"key":"213_CR35","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/joim.12160","volume":"275","author":"JT Bjerrum","year":"2014","unstructured":"Bjerrum JT, Nyberg C, Olsen J, Nielsen OH. Assessment of the validity of a multigene analysis in the diagnostics of inflammatory bowel disease. J Intern Med. 2014;275:484\u201393.","journal-title":"J Intern Med"},{"issue":"11","key":"213_CR36","doi-asserted-by":"crossref","first-page":"e0166455","DOI":"10.1371\/journal.pone.0166455","volume":"15","author":"F Manguso","year":"2016","unstructured":"Manguso F, Bennato R, Lombardi G, Riccio E, Costantino G, Fries W. Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis. PLoS One. 2016;15(11):e0166455.","journal-title":"PLoS One"},{"key":"213_CR37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MPG.0b013e318156a834","volume":"47","author":"H Mossop","year":"2008","unstructured":"Mossop H, Davies P, Murphy MS. Predicting the need for azathioprine at first presentation in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2008;47:123\u20139.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"213_CR38","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1002\/ibd.21653","volume":"17","author":"S Willot","year":"2011","unstructured":"Willot S, Noble A, Deslandres C. Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center. Inflamm Bowel Dis. 2011;17:2521\u20136.","journal-title":"Inflamm Bowel Dis"},{"key":"213_CR39","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/MPG.0000000000000533","volume":"59","author":"JR Kelsen","year":"2014","unstructured":"Kelsen JR, Grossman AB, Pauly-Hubbard H, Gupta K, Baldassano RN, Mamula P. Infliximab therapy in pediatric patients 7\u00a0years of age and younger. J Pediatr Gastroenterol Nutr. 2014;59:758\u201362.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"18","key":"213_CR40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2036.2003.01686.x","volume":"15","author":"JM Gornet","year":"2003","unstructured":"Gornet JM, Couve S, Hassani Z, Delchier JC, Marteau P, Cosnes J, et al. Infliximab for refractory ulcerative colitis or indeterminate colitis: an open-label multicentre study. Aliment Pharmacol Ther. 2003;15(18):175\u201381.","journal-title":"Aliment Pharmacol Ther"},{"issue":"18","key":"213_CR41","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1365-2036.2003.01739.x","volume":"1","author":"KA Papadakis","year":"2003","unstructured":"Papadakis KA, Treyzon L, Abreu MT, Fleshner PR, Targan SR, Vasiliauskas EA. Infliximab in the treatment of medically refractory indeterminate colitis. Aliment Pharmacol Ther. 2003;1(18):741\u20137.","journal-title":"Aliment Pharmacol Ther"},{"key":"213_CR42","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.cgh.2008.05.010","volume":"6","author":"S Caspersen","year":"2008","unstructured":"Caspersen S, Elkjaer M, Riis L, Pedersen N, Mortensen C, Jess T, Sarto P, et al. Infliximab for inflammatory bowel disease in Denmark 1999\u20132005: clinical outcome and follow-up evaluation of malignancy and mortality. Clin Gastroenterol Hepatol. 2008;6:1212\u20137.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"213_CR43","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s10350-005-0059-z","volume":"48","author":"CJ Brown","year":"2005","unstructured":"Brown CJ, Maclean AR, Cohen Z, Macrae HM, O\u2019Connor BI, McLeod RS. Crohn\u2019s disease and indeterminate colitis and the ileal pouch-anal anastomosis: outcomes and patterns of failure. Dis Colon Rectum. 2005;48:1542\u20139.","journal-title":"Dis Colon Rectum"},{"key":"213_CR44","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/archsurg.137.6.690","volume":"137","author":"MT Dayton","year":"2002","unstructured":"Dayton MT, Larsen KR, Christiansen DD. Similar functional results and complications after ileal pouch-anal anastomosis in patients with indeterminate vs ulcerative colitis. Arch Surg. 2002;137:690\u20134.","journal-title":"Arch Surg"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-017-0213-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-017-0213-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-017-0213-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T04:10:48Z","timestamp":1658549448000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-017-0213-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,1]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["213"],"URL":"https:\/\/doi.org\/10.1007\/s40272-017-0213-9","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,1]]}}}